Circulation. 2004;109:1823-1825
Published online before print April 5, 2004,
doi: 10.1161/01.CIR.0000126283.99195.37
(Circulation. 2004;109:1823-1825.)
© 2004 American Heart Association, Inc.
Brief Rapid Communications |
Water Potentiates the Pressor Effect of Ephedra Alkaloids
Jens Jordan, MD;
John R. Shannon, MD;
André Diedrich, MD;
Bonnie Black, RN;
David Robertson, MD;
Italo Biaggioni, MD
From the Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tenn (J.R.S., A.D., B.B., D.R., I.B.), and Franz Volhard Clinical Research Center and HELIOS Klinikum-Berlin, Medical Faculty of the Charité, Humboldt-University, Berlin, Germany (J.J.).
Correspondence to Italo Biaggioni, MD, 1500 21st Ave South, Suite 3500, Vanderbilt University, Nashville, TN 37212. E-mail italo.biaggioni{at}vanderbilt.edu
Received January 5, 2004; revision received March 2, 2004; accepted March 3, 2004.
 |
Abstract
|
|---|
Background The use of ephedra alkaloids in over-the-counter
preparations has been associated with potentially serious cerebrovascular
events. Because of its potential association with hemorrhagic
strokes, phenylpropanolamine has been largely substituted for
by pseudoephedrine, but it is not clear whether this is indeed
a safer alternative. It would be important to understand the
cardiovascular effects of ephedra alkaloids, but these are normally
masked by baroreflex buffering mechanisms. We therefore investigated
the effects of ephedra alkaloids in patients with autonomic
impairment and explored their potential interaction with water
ingestion.
Methods and Results The cardiovascular effects of phenylpropanolamine or pseudoephedrine, alone and in combination with water, were determined in 13 subjects with impairment of baroreflex function due to autonomic failure. Phenylpropanolamine, 12.5 to 25 mg PO, increased systolic blood pressure (SBP) by 21±14 mm Hg after 90 minutes. However, when ingested with 16 oz of room temperature tap water, phenylpropanolamine increased SBP by 82±2 mm Hg. Pseudoephedrine, 30 mg PO, increased SBP on average 52±9 mm Hg when taken with 16 oz of water and by as much as 88 mm Hg.
Conclusions Ephedra alkaloids increase blood pressure significantly in individuals with impaired baroreflex function. Concomitant ingestion of ephedra alkaloids and water produced a greater increase in blood pressure. If used cautiously, this interaction can be beneficial in the treatment of orthostatic hypotension. On the other hand, it could contribute to the cardiovascular complications associated with the use of ephedra alkaloids, given that baroreflex function varies widely in normal individuals and is impaired in several medical conditions.
Key Words: blood pressure pharmacology stroke
 |
Introduction
|
|---|
Serious cerebrovascular toxicity has been reported in people
taking dietary supplements that contain ephedra alkaloids. In
a case-control study, phenylpropanolamine ingestion was associated
with an increased risk for hemorrhagic strokes in women.
1 An
increase in blood pressure after drug ingestion may contribute
to this risk. The increase in blood pressure produced by any
pressor agent is normally attenuated by baroreflex buffering
that leads to a compensatory decrease in heart rate and sympathetic
tone. Accordingly, the pressor effect of phenylpropanolamine
is augmented in patients with impaired baroreflex function due
to autonomic failure.
2 Even in otherwise healthy people, the
ability of the baroreflex to buffer changes in blood pressure
varies 10- to 20-fold.
3 Thus, a subgroup of healthy subjects
may be particularly sensitive to pressor agents such as phenylpropanolamine.
Individuals with impaired baroreflex function are also hypersensitive
to "trivial" stimuli that occur during daily life. For example,
water drinking elicits a profound pressor response in patients
with autonomic failure.
4 We reasoned that concomitant ingestion
of water and ephedra alkaloids may induce a particularly large
pressor response. Phenylpropanolamine has largely been replaced
in the US market by pseudoephedrine. It is not certain, however,
whether pseudoephedrine has an improved safety profile. We therefore
examined the potential interaction between phenylpropanolamine
or pseudoephedrine and water drinking.
 |
Methods
|
|---|
We studied 13 patients (age 66±3 years, 8 men) with autonomic
failure due to multiple system atrophy (n=5) or pure autonomic
failure (n=8) referred for severe orthostatic hypotension, to
determine the use of short-acting pressor agents in their treatment.
Patients with pure autonomic failure had isolated severe impairment
of autonomic reflexes without a discernible cause (eg, medications,
secondary causes of neuropathy). Patients with multiple system
atrophy had either parkinsonian or cerebellar features, in addition
to autonomic failure. All studies were approved by the institutional
review board of Vanderbilt University. Written informed consent
was obtained. All tests were conducted with patients in the
seated position after an overnight fast, on separate days. Blood
pressure was determined every 5 minutes by an automated brachial
blood pressure cuff. In a first study in 4 patients, we compared
the effect of 480 mL of tap water given together with placebo,
50 mL of tap water together with phenylpropanolamine, and 480
mL of tap water together with phenylpropanolamine in a crossover
fashion. Room-temperature water was used and was ingested in
less than 5 minutes. The dose of phenylpropanolamine was individualized
in each patient (12.5 or 25 mg) to avoid excessive hypertension.
2 This study was terminated because phenylpropanolamine was, in
effect, taken off the market. In a second study, 9 patients
received 30 mg of pseudoephedrine, and, on separate days, they
drank either 50 or 480 mL of tap water 15 minutes after pseudoephedrine
ingestion. Results are presented as mean±SEM. ANOVA with
repeated measurements was used for multiple comparisons. The
level of significance was set at

=0.05.
 |
Results
|
|---|
All patients had severe disabling orthostatic hypotension, with
an average decrease in systolic blood pressure of 84±8
mm Hg (range 34 to 142 mm Hg, from 156±6 to 72±5
mm Hg). Heart rate increased from 70±4 to 80±5
bpm, an inappropriate increase given the magnitude of hypotension.
Patients had an exaggerated depressor response during phase
II of the Valsalva maneuver (60±7 mm Hg, range
25 to 105 mm Hg, versus 20±6 mm
Hg in normal subjects) and an impaired baroreflex-mediated increase
in heart rate relative to the fall in blood pressure (0.18±0.02
versus 2.90±0.62 bpm/mm Hg in normal subjects). All these
findings are consistent with a profound impairment in baroreflex
regulation of both heart rate and vasomotor tone.
Phenylpropanolamine (16±2.8 mg) taken with 50 mL of water increased seated systolic blood pressure by 21±14 mm Hg after 90 minutes (Figure 1). When the same patients ingested 480 mL of water without phenylpropanolamine, systolic blood pressure rapidly rose, reaching a maximum increase of 24±13 mm Hg above baseline after 25 minutes. The combination of phenylpropanolamine and 480 mL of water resulted in a rapid and profound pressor response of 82±2.3 mm Hg after 70 minutes (P<0.0001 between interventions by ANOVA). No change in heart rate was observed during 480 mL of water or phenylpropanolamine alone; heart rate decreased by 7±1 bpm in patients receiving phenylpropanolamine and 480 mL of water.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1. Change in systolic blood pressure in patients with autonomic failure after administration of phenylpropanolamine (PPA). Pressor effect of phenylpropanolamine taken with 50 mL of water is compared with pressor effect of same dose of phenylpropanolamine taken with 480 mL of water and with pressor effect of 480 mL of water alone. P<0.0001 between interventions by ANOVA.
|
|
When patients ingested pseudoephedrine with 50 mL of water, seated systolic blood pressure increased to a maximum of 22±10 mm Hg after 55 minutes, from a baseline seated blood pressure of 108±7 mm Hg (Figure 2). Water drinking after ingestion of the pseudoephedrine augmented the pressor response substantially. The maximal increase in systolic blood pressure was 52±9 mm Hg after 60 minutes, from a baseline seated blood pressure of 95±5 (P<0.001 between interventions). Heart rate decreased by 6±1 and 7±1 bpm with pseudoephedrine alone and pseudoephedrine plus 480 mL of water, from a baseline of 73±6 and 73±5 bpm, respectively. Blood pressure returned toward baseline values by 2 hours.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 2. Changes in systolic blood pressure (SBP) in patients with autonomic failure after ingestion of pseudoephedrine with or without water. On separate days, patients took pseudoephedrine at time 0 with either 50 or 480 mL of water given 15 minutes after pseudoephedrine. Probability value is for differences between groups by ANOVA. Asterisks denote significant differences between individual data pairs.
|
|
 |
Discussion
|
|---|
The novel finding of the present study is that water drinking
profoundly enhances the pressor response to the ephedra alkaloids
phenylpropanolamine and pseudoephedrine in subjects with impaired
baroreflex function. Systolic blood pressure increased on average
82 mm Hg when phenylpropanolamine was taken with water and 52
mm Hg when 30 mg of pseudoephedrine was taken with water (range
37 to 88 mm Hg). To the best of our knowledge, an acute interaction
of similar magnitude has not been reported for any other cardiovascular
drug and a component of the regular diet.
The interaction between ephedra alkaloids and water drinking may be explained by the fact that water itself can raise blood pressure. We observed recently that drinking 480 mL of water increases systolic blood pressure more than 30 mm Hg in patients with severe autonomic failure.4 Water drinking also increases blood pressure moderately in otherwise healthy older subjects but very little in younger subjects.4 The pressor response appears to be mediated by the sympathetic nervous system, because water drinking increases muscle sympathetic nerve traffic5 and venous plasma norepinephrine concentrations in healthy subjects.46 Moreover, ganglionic blockade with trimethaphan abolishes the water pressor response.4 The present study demonstrates that combination of the sympathetic response elicited by water drinking and the adrenergic stimulus provided by ephedra alkaloids elicits an additive, and perhaps synergistic, effect on blood pressure.
We studied the interaction between ephedra alkaloids and water drinking in a population with greatly impaired baroreflex function, which made them hypersensitive to vasoactive medications. Denervation hypersensitivity can also contribute to enhanced pressor response to adrenoreceptor agonists in these patients. It is likely that these responses are masked in healthy subjects with intact baroreflex function. However, baroreflex function varies substantially even in the general population.3,7 The variability in baroreflex function is explained by genetic factors; age; medical conditions such as obesity, hypertension, diabetes, and heart failure; and other variables. Moreover, the doses of ephedra alkaloids that are used for various indications substantially exceed the doses applied in the present study. For instance, we used 30 mg of pseudoephedrine in the present study, the lowest dose found in over-the-counter nasal decongestants, and doses up to 240 mg are available as slow-release preparations. It is possible, therefore, that water drinking may also increase the response to ephedra alkaloids in otherwise healthy subjects with low normal baroreflex function and more so in patients with impaired baroreflex function.
Our findings may have important clinical implications. If used cautiously, we can exploit this interaction to our advantage in the treatment of patients with orthostatic hypotension. Conversely, inadvertent ingestion of pressor agents and water may cause potentially dangerous pressure surges in subjects with impaired baroreflex function and in patients with autonomic failure (eg, diabetic neuropathy). Future studies would need to assess whether this interaction contributes to the cardiovascular risks associated with these drugs in the general population.
 |
Acknowledgments
|
|---|
This study was supported in part by National Institutes of Health
grants 1RO1 HL67232, 1PO1 HL56693, and RR00095. Dr Jordan is
supported by the Deutsche Forschungsgemeinschaft and receives
a Helmholtz scholarship from the Max-Delbrueck-Centrum (MDC).
The authors would like to thank the nurses and personnel of
Vanderbilts General Clinical Research Center for their
invaluable help in the evaluation of these patients.
 |
References
|
|---|
- Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000; 343: 18261832.[Abstract/Free Full Text]
- Biaggioni I, Onrot J, Stewart CK, et al. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA. 1987; 258: 236239.[Abstract]
- Jordan J, Tank J, Shannon JR, et al. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation. 2002; 105: 14591464.[Abstract/Free Full Text]
- Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation. 2000; 101: 504509.[Abstract/Free Full Text]
- Scott EM, Greenwood JP, Gilbey SG, et al. Water ingestion increases sympathetic vasoconstrictor discharge in normal human subjects. Clin Sci (Lond). 2001; 100: 335342.[Medline]
[Order article via Infotrieve]
- Geelen G, Greenleaf JE, Keil LC. Drinking-induced plasma vasopressin and norepinephrine changes in dehydrated humans. J Clin Endocrinol Metab. 1996; 81: 21312135.[Abstract]
- Tank J, Jordan J, Diedrich A, et al. Genetic influences on baroreflex function in normal twins. Hypertension. 2001; 37: 907910.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
M. Boschmann and F. Thielecke
The Effects of Epigallocatechin-3-Gallate on Thermogenesis and Fat Oxidation in Obese Men: A Pilot Study
J. Am. Coll. Nutr.,
August 1, 2007;
26(4):
389S - 395S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Raj, I. Biaggioni, B. K. Black, A. Rali, J. Jordan, I. Taneja, P. A. Harris, and D. Robertson
Sodium Paradoxically Reduces the Gastropressor Response in Patients With Orthostatic Hypotension
Hypertension,
August 1, 2006;
48(2):
329 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yamasaki, T. Ushida, T. Yokoyama, M. Ando, K. Yamashita, and T. Sato
Artificial Baroreflex: Clinical Application of a Bionic Baroreflex System
Circulation,
February 7, 2006;
113(5):
634 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|